U.S. Senate Finance Committee Chair Ron Wyden (D-OR) issued a release on 4 April 2022 regarding his continued investigation into the tax practices of multinational pharmaceutical companies to abuse tax havens and avoid paying U.S. tax.

---

Senator Wyden Continues Investigation into Big Pharma Tax Practices

Following letters to AbbVie and Bristol Myers Squibb, Wyden requests information fro…